Genmab — Marts 2019
-
-
FDA Puts Partial Hold on Venetoclax’s Multiple Myeloma Trials https://myelomaresearchnews.com/2019/03/27/fda-partially-stops-venetoclax-clinical-trials-in-multiple-myeloma/?utm_source=Myeloma+List&utm_campaign=5e5e2e74d5-RSS_WEEKLY_EMAIL_CAMPAIGN&utm_medium=email&utm_term=0_14fcd0022a-5e5e2e74d5-72491777
-
Dara-Veneto suspenderet https://clinicaltrials.gov/ct2/show/NCT03701321?term=NCT03701321&rank=1
-
Enig Lego.
-
-
Fra FirstWord Pharma : Glowing Tumors Show Scientists Where Cancer Drugs are Worning. - The technique uses PET imaging of a synthesized radiolabeled protein that locks on to tumor cells, letting researchers visually follow where a socalled checkpoint inhibitor drug binds to a tumor as- it disperses. " this approach offers a vital step toward directly measuring how well immunotherapi drugs are able to engage a tumor in any given person " says Sridhar Nimmagadda Ph.D at the John Hopkins .
-
God morgen
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind